CRP and metabolic dysfunction-associated steatotic liver disease: Two reviewers used a standardized form to extract data, including study design, sample size, population characteristics, NAFLD/MAFLD diagnostic methods, and outcomes related to HOMA-IR and other biomarkers such as triglyceride (TyG) and C-reactive protein (CRP).